(0.7-19.7). None of the patients developed major complications. After the average follow-up period of 6.5 months (3-18), all patients were symptom-free without medication. Conclusions: RFA and TCA can be performed successfully in neonates and infants with incessant medically refractory SVT. (Cardiol J 2013; 20, 3: 241-246)